Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
Zerodha (Trading Account)
FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
|
Track all the latest updates and news of Akums Drugs and Pharmaceuticals IPO.
August 5, 2024 9:35:00 AM
Akums Drugs IPO Allotment: Akums Drugs and Pharmaceuticals IPO closed its subscription to investors on August 01. Akums Drus is a pharmaceutical contract development and manufacturing organisation ...
Published by : MSNJuly 30, 2024 10:20:00 AM
Akums Drugs and Pharmaceuticals, a leading pharmaceutical contract development and manufacturing organization (CDMO), is set to open its Initial Public Offering (IPO) for subscription today ...
Published by : Times Now on MSNAugust 2, 2024 12:23:00 PM
Delhi-based Akums Drugs, a pharmaceutical contract development and manufacturing organisation is expected to announce the allotment status of its initial public offering (IPO) on Friday ...
Published by : Business Insider IndiaNovember 25, 2022 3:07:00 PM
Akums Drugs and Pharmaceuticals IPO: The Rs 1,856.7-crore offer comprised a fresh issue and an offer-for-sale component. The profit per lot comes up to Rs 1,012. The Akums Drugs IPO comprises a ...
Published by : moneycontrol.comJuly 29, 2024 10:15:00 AM
Three mainboard companies and seven SMEs will begin their IPOs this week. Ola Electric is the biggest IPO that is scheduled to begin this week. Here’s everything you need to know about the ...
Published by : Business Insider IndiaNovember 1, 2024 4:30:00 AM
Involves transaction of at least 0.5% of the listed shares of a company. Akums Drugs & Pharmaceuticals Ltd share price was up by 1.63% from the previous closing price of ?841.90. Who are peers ...
Published by : Business TodayOctober 18, 2024 8:02:00 PM
We have examined the attached Restated Consolidated Financial Information of Akums Drugs and Pharmaceuticals Limited ... Public Offer of equity shares ("IPO") prepared in terms of the requirements ...
Published by : India InfolineAugust 20, 2024 10:43:00 PM
As of 11:32 AM GMT+5:30. Market Open. MoffettNathanson senior analyst Robert Fishman joins Alexandra Canal on Market Domination Overtime to discuss the state of streaming as deals between big ...
Published by : Yahoo FinanceOctober 7, 2024 2:37:00 PM
The opening of three month lock-in being released for recent IPOs include Sanstar, Akums Drugs, Ceigall India, Ola Electric Mobility, Unicommerce Esolutions, Brainbees, Interarch Building Products ...
Published by : Business LineOctober 25, 2024 6:19:00 AM
Septerna is seeking a valuation of $743.1 million in its upsized U.S. initial public offering, the Goldman Sachs-backed drug developer said on Thursday, a sign of upbeat investor sentiment for the ...
Published by : ReutersOctober 21, 2024 6:10:36 PM
With U.S. elections about two weeks away, the U.S. IPO market appears to be slowing down as investors await the formation of the new government. Last week, Chin ...
Published by : Seeking Alpha on MSNOctober 7, 2024 7:28:00 PM
Rivus Pharmaceuticals Inc., a drug developer focused on obesity treatments, is considering a US initial public offering as soon as 2024, according to people with knowledge of the matter.
Published by : Bloomberg L.P.The IPO Shares of Akums Drugs and Pharmaceuticals Limited IPO are proposed to list on Tuesday, August 6, 2024 at BSE, NSE. The public issue of Akums Drugs and Pharmaceuticals IPO was opened on Jul 30, 2024 and closed for subscription on Aug 1, 2024. Akums Drugs and Pharmaceuticals IPO Listing Date and Information:
| Listing Date | Tuesday, August 6, 2024 |
| BSE Script Code | 544222 |
| NSE Symbol | AKUMS |
| Listing In | B Group of Securities |
| ISIN | INE09XN01023 |
| Issue Price | ₹679 Per Equity Share |
| Face Value | ₹2 Per Equity Share |
The allotment status of Akums Drugs and Pharmaceuticals Limited IPO is now available online. The public issue of Akums Drugs and Pharmaceuticals IPO was open on Jul 30, 2024 and closed for subscription on Aug 1, 2024. The equity shares of the company to be list at BSE, NSE
.Akums Drugs and Pharmaceuticals Limited is entering in the capital market with an IPO of 27,345,162 Equity Shares of Rs 2 aggregating up to Rs 1,856.74 Crore. The price for the issue has been set at Rs 646 - Rs 679 Per Equity Share.
Established in 2004, Akums Drugs and Pharmaceuticals Limited is a pharmaceutical contract development and manufacturing organization (CDMO) offering a comprehensive range of pharmaceutical products and services in India and overseas.
The issue opens on Jul 30, 2024 and closes for subscription on Aug 1, 2024. The equity shares of the company to be list at BSE, NSE.
The issue of Akums Drugs and Pharmaceuticals Limited opens on Jul 30, 2024 and closes for subscription on Aug 1, 2024. The equity shares of the company to be list at BSE, NSE. The price for the issue has been set at Rs 646 - Rs 679 Per Equity Share.
The Akums Drugs and Pharmaceuticals IPO is proposed to open on July 30, 2024. The IPO application ends on August 1, 2024.
Retail investors can apply in the retail or non-institutional investor category from July 30, 2024 to August 1, 2024. The Akums Drugs and Pharmaceuticals IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).
The Akums Drugs and Pharmaceuticals IPO will open for subscription on July 30, 2024. The public issue will close on August 1, 2024.
Useful Articles
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|
|
RHP
